Pharmacopoeia of the People's Republic of China 2020

The Pharmacopoeia of the People's Republic of China 2020 edition is the 11th edition. It covers both traditional Chinese medicine and Western medicines. It gives descriptions and information of purity, testing, dosage, precautions, storage and strength of each drug.

The latest edition of Chinese Pharmacopoeia was released on July 2, 2020, and took effect on December 30, 2020. this edition of pharmacopoeia includes 5911 monographs, 319 new additions, 3177 revisions, 10 rejections, and 6 reductions due to the merger of monographs.

Published in four volumes:

• Volume I - includes 2711 monographs of traditional Chinese medicines (TCMs), including 117 additions, and 452 revisions.

• Volume II - includes 2712 monographs of chemical drugs, including 117 additions, and 2387 revisions.

• Volume III - includes 153 monographs of biological products, including 20 additions, and 126 revisions; 2 general requirements and 4 general monographs of biological products are newly added.

• Volume IV - includes 361 general technical requirements, including 38 general requirements for preparations (35 revisions), 281 general testing methods and other general chapters (35 additions, 51 revisions), 42 guidelines (12 additions, 12 revisions); 335 monographs of pharmaceutical excipients, including 65 additions, and 212 revision.

• General Notice - General Tests, Processes and Apparatus

• Official Monographs (A to L)

• Official Monographs (M to Z)

• Crude Drugs and Related Drugs

• Infrared Reference Spectra

• Ultraviolet-visible Reference Spectra

• General Information